Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-year European multicenter study with repeat [123I]FP-CIT SPECT

Movement Disorders

Volumn 24, Issue 4, 2009, Pages 500-508

  Marshall, Vicky L ^a   Reininger, Cornelia B ^b   Marquardt, Moritz ^b   Patterson, Jim ^a   Hadley, Donald M ^a   Oertel, Wolfgang H ^c   Benamer, Hani T S ^d   Kemp, Paul ^e   Burn, David ^f   Tolosa, Eduardo ^g   Kulisevsky, Jamie ^h   Cunha, Luis ⁱ   Costa, Durval ^j   Booij, Jan ^k   Tatsch, Klaus ^l   Chaudhuri, K Ray ^m   Ulm, Gudrun ⁿ   Pogarell, Oliver ^o   Höffken, Helmut ^c   Gerstner, Anja ^c   Grosset, Donald G ^a   more..

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b Clinical Research and Development   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d NEW CROSS HOSPITAL   (United Kingdom)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^f NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^j HPP Medicina Molecular SA   (Portugal)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m KING S COLLEGE HOSPITAL   (United Kingdom)

ⁿ Paracelsius Elena Klinik   (Germany)

^o UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

123I FP CIT; Parkinson's disease; SPECT; SWEDD

Indexed keywords

IOFLUPANE; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)NORTROPANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; VIDEORECORDING; COMPARATIVE STUDY; EUROPE; HOSPITALIZATION; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PHYSIOLOGY; REFERENCE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; EUROPE; FEMALE; HUMANS; IODINE RADIOISOTOPES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 67651151386     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22108     Document Type: Article

References (33)

1. Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999;28:99-102.
2. Schrag A, Ben Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002;73:529-534.
3. Chaudhuri KR, Buxton-Thomas M, Dhawan V, et al. Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry 2005;76:115-117.
4. Louis ED, Wendt KJ, Pullman SL, et al. Is essential tremor symmetric? Observational data from a community-based study of essential tremor. Arch Neurol 1998;55:1553-1559.
5. Cohen O, Pullman S, Jurewicz E, et al. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiological characteristics. Arch Neurol 2003;60:405-410.
6. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
7. Jennings DL, Seibyl JP, Oakes D, et al. [123I] b-CIT and singlephoton emission computed tomographic imaging vs clinical evaluation in parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 2004;61:1224-1229.
8. Hughes AJ, Daniel SE, Ben Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
9. Jankovic J, Rajput A, McDermott M. The Evolution of Diagnosis in Early Parkinson Disease. Arch Neurol 2000;57:369-372.
10. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57:1497-1499.
12. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181.
13. Stiasny-Kolster K, Doerr Y, Moller JC, et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for {alpha}-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005;128:126-137.
14. Benamer TS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503-510.
15. Parkinson Study Group. A multicentre assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Neurology 2000;55:1540-1547.
16. Benamer HT, Oertel WH, Patterson J, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord 2003;18:977-984.
17. Gibb WRG, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropath Appl Neurobiol 1989;15:27-44.
18. Findley LJ, Koller WC. Definitions and behavioural classifications. In: Findley LJ, Koller WC, editors. New York: Marcel Dekker; 1995. pp 1-5.
19. Booij J, Hemelaar TG, Speelman JD, et al. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT. J Nucl Med 1999;40:753-761.
20. Jellinger KA. How valid is the clinical diagnosis of Parkinson's disease in the community?[comment]. J Neurol Neurosurg Psychiatry 2003;74:1005-1006.
21. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991;18:275-278.
22. Booij J, Speelman JD, Horstink MW, et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001;28:266-272.
23. Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002;287:1653-1661.
24. Parkinson Study Group. Levodopa and the Progression of Parkinson's Disease. N Engl J Med 2004;351:2498-2508.
25. Whone AL, Watts RL, Stoessl AJ, et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: the REALPET study. Ann Neurol 2003;54:93-101.
26. Seibyl J, Jennings D, Tabamo R, et al. Neuroimaging trials of Parkinson's disease progression. J Neurol 2004;251:VII/9-VII/13.
27. Marek K, Jennings DL, Seibyl JP. Long-Term Follow-Up of Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD) in the ELLDOPA Study. Neurology 2005;64 (Suppl 1):A274(Abstract).
28. Seibyl J, Jennings D, Tabamo R, et al. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease. Minerva Med 2005;96:353-364.
29. Fahn S, Shoulson I, Kieburtz K, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004;351:2498-2508.
30. Marek KL. Dopamine transporter imaging-challenging the evidence, platform presentation at the International Congress on Parkinson's Disease and Related Disorders, Berlin, Germany, 2005.
31. Eckert T, Feigin A, Lewis DE, et al. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 2007;22:167-173.
32. Schneider SA, Edwards MJ, Mir P, et al. Patients with adultonset dystonic tremor resembling parkinsonian tremor have scans without evidence Of dopaminergic deficit (SWEDDs). Mov Disord 2007;22:2210-2215.
33. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004;19:1196-1202.